Novo Nordisk maintains booming sales of obesity and diabetes drugs
6 Nov 2024
Maker of blockbuster Wegovy and Ozempic treatments reports 21% rise in third-quarter sales
Read full article at _Financial Times
6 Nov 2024
Maker of blockbuster Wegovy and Ozempic treatments reports 21% rise in third-quarter sales
Read full article at _Financial Times